

iShares U.S. Healthcare ETF
$71.47−0.61 (−0.85%)
- Expense ratio
- 0.37%
- Fund size
- $3.9B
- 1Y return
- +26.3%
- Yield · Last 12 months
- 1.11%
- Holdings
- 100
- Volume · 30D
- 0.8M sh
- NAV per share
- $71.60
- 52W range
The ETF.net IYH Grade
Score 69 of 100 sits in the B band. Bands: A ≥ 70, B ≥ 55, C ≥ 40, D ≥ 25, F < 25; the scale skips E.
Cost
What you pay to own it — the expense ratio plus trading frictions, ranked within its category.BScore 69Category rankMission
How faithfully it does the job it claims — tracking its mandate or index with minimal slippage.Not scoredRisk
How violently it can move — volatility, drawdown depth, and downside capture versus its category.AScore 72Category rankTradability
How cheaply and easily you can get in and out — liquidity, spread, and premium/discount stability.AScore 83Category rankHoldings
What it actually owns — the quality, breadth, and concentration of the underlying portfolio.CScore 42Category rankDurability
Whether it will still be here — the fund’s assets, age, flows, and issuer staying power.AScore 83Category rank
Our read on IYH
BA healthcare sector ETF from the class of 2000. It tracks a Russell 1000 healthcare index of roughly 100 US names, pharma to devices, with rules that keep any one stock from swallowing the fund.
The fund is designed to follow a healthcare-sector equity index focused on U.S. companies, while providing diversified exposure to pharmaceuticals, biotechnology, and healthcare equipment.
Why people hold it
- Launched in 2000, one of the longest-running US healthcare sector funds, run by iShares through multiple market cycles.
- The 0.38% fee sits below the 0.50% median for broad healthcare sector funds.
- A Russell 1000 base spreads roughly 100 names across pharma, biotech and healthcare equipment, reaching past the mega-cap handful.
- A multi-billion-dollar, actively traded fund that pays quarterly, and it ranks in the upper half of its healthcare peer group.
Worth knowing
- Cheaper doors into the same sector exist: VHT at 0.09%, FHLC and XLV at 0.08%. The wider Russell 1000 basket is what you pay up for.
- This is one slice of the market. Drug pricing rules, patent expirations and policy headlines move the whole basket together.
- The index applies diversification caps, trimming the largest names instead of letting them run, so weights can drift from a plain market-cap healthcare basket.
IYH Holdings
- Stocks
- 100
- 59%
- LLY
Sectors
- Health Care99.4%
- Technology0.6%
Geography
- United States96.94%
- Ireland2.42%
- United Kingdom0.31%
- Denmark0.19%
- Netherlands0.14%
IYH Performance
Shows how $10,000 changes over the selected period, with cash distributions reinvested at the closing price on each ex-dividend date.
Returns run to the Sep 22, 2026 close, with cash distributions reinvested. Each period starts on the same date that many months or years earlier. Periods over one year show the average yearly return.
| Period | IYH |
|---|---|
| Year to date | +11.7% |
| 1 month | −2.2% |
| 3 months | +14.4% |
| 1 year | +26.3% |
| 3 years | +11.1% |
| 5 years | +6.0% |
| 10 years | +10.3% |
Calendar-year total return with cash distributions hypothetically reinvested at the ex-dividend date’s closing price. The current year shows year to date.
| Year | Return bar | IYH |
|---|---|---|
| 2026 YTD | +11.7% | |
| 2025 | +13.2% | |
| 2024 | +3.0% | |
| 2023 | +2.2% | |
| 2022 | −4.5% | |
| 2021 | +23.4% | |
| 2020 | +15.6% |
IYH in the news
IYH Dividends
- 1.11%
- $0.80
- $0.19 per share
- Quarterly
Distribution history
| Ex-date | Pay date | Amount per share |
|---|---|---|
| Sep 15, 2026 | Sep 18, 2026 | $0.19 |
| Jun 15, 2026 | Jun 18, 2026 | $0.16 |
| Mar 17, 2026 | Mar 20, 2026 | $0.19 |
| Dec 16, 2025 | Dec 19, 2025 | $0.25 |
| Sep 16, 2025 | Sep 19, 2025 | $0.19 |
| Jun 16, 2025 | Jun 20, 2025 | $0.17 |
| Mar 18, 2025 | Mar 21, 2025 | $0.16 |
| Dec 17, 2024 | Dec 20, 2024 | $0.20 |
| Sep 25, 2024 | Sep 30, 2024 | $0.23 |
| Jun 11, 2024 | Jun 17, 2024 | $0.13 |
| Mar 21, 2024 | Mar 27, 2024 | $0.17 |
| Dec 20, 2023 | Dec 27, 2023 | $0.18 |
IYH Risk
- 14.2%
How it’s calculated: standard deviation
The sample standard deviation of monthly total returns, multiplied by the square root of 12.
Uses up to 36 complete months, with at least 12 required. Total returns include reinvested distributions.
- 0.42
How it’s calculated: Sharpe ratio
Subtract each month’s Treasury-bill return from the fund’s monthly total return.
Divide the average of those excess returns by their sample standard deviation, then multiply by the square root of 12.
Uses up to 36 complete months, with at least 12 required. Each month uses the Treasury yield quoted at the end of the previous month.
- −17.9%
How it’s calculated: maximum drawdown
The largest percentage decline from an earlier peak, using total returns with reinvested distributions.
Uses up to five years through the last close, with at least 12 months required.
- 0.52
How it’s calculated: beta
The beta figure is supplied by FMP. The comparison index depends on the fund’s broad asset class.
IYH Cost
- The middle half of Health Care (Broad) funds
- Median 0.50%
6 of the 25 Health Care (Broad) funds charge less.